Insights from 2023 SABCS
Playback speed
10 seconds
SABCS 2023 Insights: "Evaluating Low-Dose vs. Standard-Dose Olanzapine With Triple Antiemetic Therapy for Prevention of Highly Emetogenic Chemo-Induced Nausea & Vomiting in Solid Tumors"
By
Insights from 2023 SABCS
FEATURING
Jyoti Bajpai
By
Insights from 2023 SABCS
FEATURING
Jyoti Bajpai
59 views
February 28, 2024
Comments 0
Login to view comments.
Click here to Login
Videos